| | | All-cause mortality | CVD-mortality |
---|
| Quartiles | Quartlie ranges | HR (95% CI) | p-value | HR (95% CI) | p-value |
---|
Serum albumin† | Q1-Q3 | 3.2–4.4 | 1.54 (1.14–2.08) | 0.005 | 1.35 (0.84–2.17) | 0.21 |
Q4 | 4.4–5.3 |
Serum creatinine* | Q1-Q3 | 0.4–1.2 | 1.36 (0.99–1.87) | 0.06 | 2.02 (1.24–3.29) | 0.005 |
Q4 | 1.2–1.75 |
UACR* | Q1-Q3 | 0.5–37.9 | 1.81 (1.38–2.39) | 1.99×10-5 | 2.38 (1.61–3.53) | 1.50×10-5 |
Q4 | 37.9–4165.0 |
eGFR† | Q1-Q3 | 20.0–75.0 | 1.58 (1.16–2.16) | 0.004 | 1.94 (1.23–3.05) | 0.004 |
Q4 | 75.0–179.9 |
- UACR=urine albumin:creatinine ratio; eGFR=estimated glomerular filtration rate.
- Associations based on proportional hazards regression models adjusted for age, sex, type 2 diabetes affection status, body mass index, current smoking, hypertension, dyslipidemia, ACE/ARB medication use, prior CVD and coronary artery calcified plaque.
- *For serum creatinine and UACR, quartiles were established based on increasing values across the distribution such that quartile 4 (Q4) captures the highest risk individuals. †For serum albumin and eGFR, quartiles were established based on decreasing values across the distribution such that Q4 again captures the highest risk individuals.